Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$25.92 USD
+1.46 (5.97%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $25.92 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLDX 25.92 +1.46(5.97%)
Will CLDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CLDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLDX
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
CLDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?
Celldex Therapeutics (CLDX) Reports Q1 Loss, Lags Revenue Estimates
Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last?
Other News for CLDX
Is CLDX setting up for a drop? Shooting Star Candlestick shows up after sliding 0.49%
Celldex (CLDX) Reports Promising Phase 2 Results for Barzolvolimab in CSU
Celldex’s barzo shows strong efficacy in CSU patients, says H.C. Wainwright
Celldex’s Barzolvolimab Shows Promising Efficacy in Treating Chronic Spontaneous Urticaria Across Patient Subgroups
Celldex's barzo shows strong efficacy in CSU patients, says H.C. Wainwright